Web of Biological Data Act of 2026
- Sponsor
- Sen. Young, Todd [R-IN]
- Committees
- Energy and Natural Resources Committee (primary)
- Last action
- Jun 11, 2026
Bottom line
This bill aims to create a secure, centralized, and interoperable national resource for biological data to accelerate AI-driven research and maintain U.S. leadership in biotechnology.
What it actually does
This bill mandates the Secretary of Energy to establish a "Web of Biological Data" through a competitive grant to a National Laboratory. This centralized data resource will facilitate biological research using advanced computational methods like artificial intelligence by providing a single point of entry to diverse biological datasets, especially those funded by the Federal Government. It includes phased implementation, robust cybersecurity measures, and an advisory board to guide its development and ensure usability.
Proponents argue
Proponents argue that the Web of Biological Data will significantly accelerate scientific discovery, enhance national competitiveness in AI and biotechnology, and improve the accessibility and quality of biological data for researchers. They contend it will streamline data management, foster innovation, and strengthen national biosecurity by providing a controlled environment for sensitive information.
Opponents contend
Opponents or skeptics might raise concerns about the potential for data misuse, the complexity of ensuring privacy and data security across a vast centralized system, and the high costs associated with establishing and maintaining such an extensive data infrastructure. They may also point to potential bureaucratic inefficiencies in coordinating numerous federal agencies and external partners.
The bill is concise and well-structured, making it accessible for an informed reader to understand its core provisions and implications within a reasonable timeframe.
Sec. 2(b)
Establishment of the Web of Biological Data
This provision mandates the Secretary of Energy to establish a centralized data resource, to be known as the "Web of Biological Data," through a competitive grant to a National Laboratory within 180 days of enactment. The Web will serve as a single point of entry for researchers to access biological data, particularly federally funded data, and will include metrics for data quality and tiered cybersecurity safeguards. It also establishes a research and development program for biological data science.
Supporters argue
Supporters argue that centralizing access to biological data will significantly accelerate scientific discovery, reduce redundant efforts, and foster innovation in AI and biotechnology by making data more discoverable and usable.
Critics contend
Critics may express concerns about the potential for a single point of failure in data management, the complexities of data governance across diverse sources, and the challenge of ensuring true interoperability among disparate datasets.
Tradeoffs
The provision balances the benefits of broad data accessibility for research against the inherent challenges of security, interoperability, and governance for a vast, centralized data resource.
Sec. 2(c)
Director's Authority for Collaboration and Funding
This section grants the Director of the selected National Laboratory the authority to enter into various agreements to support the Web of Biological Data. These include data sharing agreements with other federal departments and agencies to integrate non-DOE biological datasets, cost-sharing agreements with non-governmental entities (like philanthropy and industry) to fund the Web, and partnerships with academia, industry, and international allies to optimize usability and performance.
Sec. 2(e)
Phase I: Initial Web Development and Testing
Within two years of enactment, the Director is required to test an initial version of the Web of Biological Data. This phase will focus on specific biological data subtypes, feature a human-centered design interface with tiered security access, and include initial frameworks for application programming interfaces (APIs) developed with the National Institute of Standards and Technology (NIST). It also mandates working with federal agencies to acquire data, developing cost-sharing agreements, and testing the system with biotechnology stakeholders.
Sec. 2(f)
Phase II: Expanded Web Accessibility and Features
Within five years of enactment, the Director must expand the Web to be fully accessible to United States researchers, accommodate diverse biological data types, and adapt to new data. This expanded version will feature a comprehensive single point-of-entry interface connected to all federally funded data, host relevant bioinformatic tools, and include a full suite of interoperability frameworks. It also requires an online interface optimizing usability with human-centered design, standardized data quality for AI training, and strict cybersecurity with data sharing restrictions.
Sec. 2(h)
Establishment of an Advisory Board
The Secretary is required to establish an 11-member advisory board within 180 days of selecting the National Laboratory. Chaired by the Director of the selected National Laboratory, the board will include representatives from industry (4), academia (2), other National Laboratories (2), and relevant federal departments and agencies (3, with at least one biosecurity expert). This board will oversee the Web's implementation and ensure it maximizes the usability of biological datasets across sectors.
Sec. 2(k)
Authorization of Appropriations
This section authorizes specific appropriations for the Web of Biological Data. It authorizes $30,000,000 for the first three years following enactment for the research and development program, $310,000,000 for the first three years for Phase I implementation, and $80,000,000 for each of the subsequent two years (after Phase I completion) to carry out the overall section. This totals $500,000,000 over a five-year period.
The initial and expanded versions of the Web must include appropriate cybersecurity and access safeguards, specifically limiting access to adversarial countries and countries that do not participate in reciprocal data sharing, as determined by the Secretary.
Sec. 2(e)(1)(D) and (f)(2)(F)
Why it matters:This is standard legislative practice to integrate security requirements directly into the operational and technical implementation details of a new system, ensuring security is built-in from the ground up.
Case for: Supporters argue this is essential for protecting sensitive biological data from foreign adversaries and ensuring national security, especially given the dual-use nature of biological research and the strategic importance of AI.
Case against: Critics might argue that such restrictions could potentially limit legitimate international scientific collaboration with countries that are not explicitly 'adversarial' but also do not have robust reciprocal data sharing agreements, potentially hindering global scientific progress on shared challenges.
Estimated impact: Significant impact on international scientific collaboration policies and the national security posture regarding biological data assets.
This rule of construction clarifies that nothing in the Act supersedes, modifies, or waives any existing applicable requirements related to privacy, informed consent, human-subject protections, data use limitations, or protections against unauthorized disclosure, misuse, or re-identification for biological data hosted or accessible through the Web.
Sec. 2(l)
Why it matters:This is a common legislative practice to include savings clauses to clarify how a new law interacts with and preserves existing legal and ethical frameworks, particularly concerning sensitive data.
Case for: Supporters argue this is crucial for ensuring that the establishment of a vast new data resource does not inadvertently undermine existing ethical and legal protections for sensitive biological data, thereby maintaining public trust and compliance with established norms.
Case against: While generally supported, some might argue that merely stating this does not fully address the inherent tension between maximizing data accessibility for research and rigorously protecting individual privacy, which could lead to complex legal interpretations and implementation challenges in practice.
Estimated impact: Ensures the continuity of existing privacy, ethical, and legal standards for biological data, preventing unintended erosion of protections.